You are visiting us from Virginia. You are located in HHS Region 3. Your Center is Central East ATTC.

Hepatitis C Prescriber Toolkit

Laura W. Cheever, MD, ScM
Associate Administrator for HRSA HIV/AIDS Bureau

Although advances in HIV care and treatment result in longer life expectancy for people with HIV, those who are coinfected with HIV and hepatitis C have a high risk of liver-related illness and death. Viral hepatitis progresses faster and causes more liver-related health problems among people with HIV than among those who do not have HIV. Approximately 25% of people with HIV are coinfected with hepatitis C.

Providers are key partners in national efforts to reduce and, ultimately, eliminate hepatitis C virus (HCV) coinfection among people with HIV. To support providers in diverse settings to effectively engage and remain up to date on state-specific prescribing requirements, the Health Resources and Services Administration’s HIV/AIDS Bureau released the Hepatitis C Prescriber Toolkit on TargetHIV.

The interactive Hepatitis C Prescriber allows providers to select their state and learn about health coverage requirements that may impact the prescription of hepatitis c treatment. The toolkit also includes additional resources such as links to the Ryan White HIV/AIDS Program (RWHAP) Part F AIDS Education and Training Center (AETC) Program’s HIV/HCV Coinfection Curriculum.

Each state-specific page provides a link to the regional AETC partner for training opportunities and additional coinfection resources. , It provides information on Medicare, the state’s Medicaid contact, the state’s AIDS Drug Assistance Program (ADAP) contact with applicable prior authorization form. Providers can also access a list of patient assistance programs if their patient is not eligible for private insurance or ADAP coverage. 

Through the efforts of the RWHAP AETCs, a number of resources have been developed to support RWHAP recipients and providers to encourage increasing hepatitis C screening and treatment to help improve the health outcomes of people with HIV. The Hepatitis C Prescriber Toolkit is one more resource for providers to have at their disposal.

Visit the toolkit today! 

Published:
02/12/2020
Tags
Recent posts
This flipbook features a compilation of published blog posts from the ATTC/NIATx Service Improvement Blog that highlights content focused on the use of NIATx principles, tools, and processes to create impactful and lasting organizational change. It also includes information on implementing the NIATx change model in new and diverse settings. By compiling the content according to these […]
Prevention coalitions often face challenges engaging parents in prevention initiatives, even when those efforts address critical issues like youth substance use or mental health. Here's an example of how a fictional coalition decided to take on this challenge by using the NIATx Plan-Do-Study-Act (PDSA) tool. The small, incremental changes they made helped to increase attendance […]
The flowchart is one of the essential tools in the NIATx model. A flowchart provides visual map of your process—it shows how things get done, step by step. You might be thinking, “Why do we need a flowchart if we already did a walk-through of the process?" If the process seems straightforward, your team might […]
Xylazine, medetomidine and nitazines are substances that are emerging as key contributors in the latest wave of the Opioid Overdose Epidemic. Xylazine is an adulterant that increases the duration of a user’s fentanyl high and delays withdrawal to some extent. Medetomidine is another adulterant that belongs to the same family of drugs as xylazine, but […]

The opinions expressed herein are the views of the authors and do not reflect the official position of the Department of Health and Human Services (DHHS), SAMHSA, CSAT or the ATTC Network. No official support or endorsement of DHHS, SAMHSA, or CSAT for the opinions of authors presented in this e-publication is intended or should be inferred.

map-markermagnifiercrossmenuchevron-down